| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.008 |